Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 6/20 | 0.37 |
| ▸ | GRM5 | P41594 | 3/20 | 0.37 |
| ▸ | MAOB | P27338 | 4/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8303658 | 1.00 | GRM2 (0.37) | GRM2GRM5MAOBMAOA | |
| SCHEMBL8308408 | 0.85 | GRM2 (0.36) | GRM2GRM5MAOBMAOA | |
| SCHEMBL8305638 | 0.80 | MAOB (0.42) | GRM2GRM5MAOBMAOA | |
| SCHEMBL3505520 | 0.76 | GRM2 (0.39) | GRM2GRM5MAOB | |
| SCHEMBL8305866 | 0.75 | MAOB (0.38) | GRM2GRM5MAOBMAOA | |
| SCHEMBL8305067 | 0.75 | GRM2 (0.39) | GRM2GRM5MAOB | |
| Hydrochloric Acid SCHEMBL8307966 | 0.75 | SMN1; SMN2 (0.38) | GRM2GRM5 | |
| SCHEMBL8303566 | 0.75 | GRM2 (0.35) | GRM2GRM5MAOBMAOA | |
| Hydrochloric Acid SCHEMBL8307968 | 0.75 | SMN1; SMN2 (0.38) | GRM2GRM5 | |
| SCHEMBL8303567 | 0.75 | GRM2 (0.35) | GRM2GRM5MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0609441-B1 | Oxazolidone derivatives as monoamine oxidase inhibitors | EISAI CO LTD (JP) | 1999-07-21 | — | — | EP | disclosed |
| US-5475014-A | Monoamine oxidase inhibor; antidepressant | EISAI CO., LTD. (JP) | 1995-12-12 | — | — | US | disclosed |
| EP-0609441-A1 | OXAZOLIDONE DERIVATIVE | Eisai Co., Ltd. (JP) | 1994-08-10 | — | — | EP | disclosed |